Sanchez-De la Nava, Ana María; Arenal, Angel; Fernández-Avilés, Francisco; Atienza, Felipe(Frontiers Media SA, 2021-12-27)
[EN] Background: Antiarrhythmic drugs are the first-line treatment for atrial fibrillation (AF), but their effect is highly dependent on the characteristics of the patient. Moreover, anatomical variability, and specifically ...
Ortigosa Calatayud, Carla(Universitat Politècnica de València, 2024-10-01)
[ES] La arritmia conocida como Torsade de Pointes (TdP) es una taquicardia ventricular potencialmente mortal que puede ser inducida por fármacos. Este hecho ha conllevado la retirada de ciertos medicamentos del mercado, ...
Drug-induced action potential (AP) prolongation leading to Torsade de Pointes is a major concern for the development
of anti-arrhythmic drugs. Nevertheless the development of improved anti-arrhythmic agents, some of which ...
Gomis-Tena Dolz, Julio; Brown, Brandon M.; Cano, Jordi; Trenor Gomis, Beatriz Ana; Yang, Pei-Chi; Saiz Rodríguez, Francisco Javier; Clancy, Colleen E.; Romero Pérez, Lucia(American Chemical Society, 2020-03-23)
[EN] Preclinical assessment of drug-induced proarrhythmicity is typically evaluated by the potency of the drug to block the potassium human ether-a-go-go-related gene (hERG) channels, which is currently quantified by the ...